Professional

Japan investigates cancer "articles"

The Heath, Labor and Welfare ministry says a publisher passed off advertorials as articles.

AMA to shutter newspaper amid ad turmoil

AMA to shutter newspaper amid ad turmoil

By

American Medical News' 55-year publishing run will come to a close this year, the AMA, its publisher, said today.

WebMD on the hunt for new business

WebMD on the hunt for new business

By

The CEO's unexpected departure is part of the health information brand's latest changes. On the table: possible acquisitions. In progress: a new federal contract and new website content. Ignored: if the company wants to be bought.

Business Briefs: Docs question Gleevec price, Sanofi pill may delay MS onset

Doctors call out Novartis on drug prices; Aubagio shows strong top-line data in trials; and overseas docs increasingly turn to digital.

Business briefs: Allergan, Amgen, Wiley

Allergan's 2013 outlook scores points with at least one analyst, Amgen is laying off 160 staff, and Wiley renews a publishing relationship.

Pradaxa dominates doc poll of most effective journal ads

Pradaxa dominates doc poll of most effective journal ads

By

The most effective journal ads of the year included executions for Pradaxa, Humira and Conceptus' Essure Procedure, according to the Doctors' Choice Study.

Docs cozy up to brands that bring unique benefits, thought-leader backing

Docs cozy up to brands that bring unique benefits, thought-leader backing

By

Physician trust in pharmaceutical brands is driven by an emotional connection as well as functional attributes and perceptions of the manufacturer, said Harris Interactive, which found Advair, Spiriva and Mirena to be tops in their categories with doctors.

Bayer's Sandra Peterson jumps to J&J, takes on consumer

By

The alumna of Bayer's crop, medical and diabetes units is taking on the title of group worldwide chairman, which comes with oversight of the global supply chain, IT and the troubled consumer unit.

New ad model fosters pharma's leap to digital, publisher finds

New ad model fosters pharma's leap to digital, publisher finds

By

Statistics show medical professionals are migrating toward iPads. Now, one medical journal publisher says, advertisers have followed.

With online doctor quiz, edugaming dons lab coat

With online doctor quiz, edugaming dons lab coat

By

Could an online quiz be the future of continuing medical education? In a twist on the "edu-gaming" phenomenon, Cleveland Clinic and physician site MDLinx aim to answer that question with The Smartest Doc, a daily one-minute quiz that aims to keep doctors up to date on the medical literature by appealing to their competitive spirit.

Sermo looks for new leaders—and profitability

Sermo looks for new leaders—and profitability

By

Sermo is searching for a CEO and a medical advisory board since the physician online community's founder, Dr. Daniel Palestrant, and chief medical officer, Dr. Adam Sharp, left in November to launch a new startup called Par8o.

Samples no longer hold sway in pharma marketing mix: study

Samples no longer hold sway in pharma marketing mix: study

By

Over the last four years, drugmakers have slashed support for samples as they rethink what once was an essential part of their marketing mix.

Merck takes stake in Physicians Interactive

By

Merck's Global Health Innovation Fund (GHIF) is investing up to $17 million in Physicians Interactive, a company that develops digital products for doctors such as e-sampling and interactive education programs.

Ipsen to bulk up commercial team as it moves US hub to NJ

By

Ipsen announced plans to reorganize its North American commercial operation by relocating the head office from California to New Jersey and hiring about 100 employees.

How Genentech cut journal ads across all Avastin indications

How Genentech cut journal ads across all Avastin indications

By

Well before the FDA revoked Avastin's approval in breast cancer, Roche's Genentech unit deeply cut the professional media plan for the drug, the company said.

Pri-Med sold; John Mooney returns as CEO

By

Pri-Med founder John Mooney and his former management team have returned to the firm, which is under new ownership following M|C Holding's sale of Pri-Med's US assets to Canadian event and media producer Diversified Business Communications.

Springer in deal to buy Wolters Kluwer pharma-related journals

By

Wolters Kluwer reached an agreement to sell its pharma-related marketing and publishing services unit to Springer Science+Business Media, the firms said today.

Branded Benlysta DTC campaign ready to roll out

By

New online and print DTC advertising targeting US patients with lupus will appear "within weeks," said executives from Human Genome Sciences. Can the campaign revive blockbuster fortunes for Benlysta?

Saatchi appoints a turnaround artist to lead NY professional shop

Saatchi appoints a turnaround artist to lead NY professional shop

By

Publicis Healthcare Communications Group named Anders Ekman managing director of Saatchi & Saatchi Health Communications New York, the flagship professional healthcare agency of the Saatchi brand.

Among doctors, Google outpaces professional search engines

By

Double the number of MDs used Google (87%) for professional research online as the next most-used search options (WebMD and PubMed, each at 43%), data from a recent survey show.

Majority of pharma journal ads not FDA-compliant: study

By

Four out of five ads analyzed in a study of physician-directed pharmaceutical advertising would definitely not pass FDA muster, or might have trouble doing so, said researchers. Their findings may have implications for the FDA, DDMAC and the "Bad Ad" program.

Global healthcare pros prefer live reps, survey finds

By

For all the talk of e-detailing and digitizing the sales force, a plurality of international healthcare professionals would rather get info about new treatments from flesh-and-blood reps than through any other channel, a survey found.

Ad for platelet-inhibition test pushes envelope, cardiologist asserts

Ad for platelet-inhibition test pushes envelope, cardiologist asserts

By

Is a medical journal ad for platelet-inhibition testing backed up by evidence that treatment guided by such testing can reduce the risk of clot formation?

Savient focuses on reimbursement for Krystexxa launch

Savient focuses on reimbursement for Krystexxa launch

By

Savient Pharmaceuticals launched Krystexxa (pegloticase), an orphan drug for chronic gout, on Monday, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers, executives said on a conference call.

Forest Labs to acquire Clinical Data, add reps for Viibryd launch

Forest Labs to acquire Clinical Data, add reps for Viibryd launch

By

Forest Labs will acquire Clinical Data for $1.2 billion, and expand its primary care sales forces in preparation for the launch of Viibryd (vilazodone HCI), executives said in a call this morning.

Sales reps say medical knowledge, business acumen are keys to access

By

A large survey of sales reps found that knowledge of evidence-based medicine and clinical practice guidelines, as well as information related to managing the business aspects of a healthcare practice, are the two best ways to get a foot in the door with physicians

Sunovion reps deployed for Latuda

Sunovion reps deployed for Latuda

By

Sunovion Pharmaceuticals is targeting 22,000 psychiatrists in the US, with a sales force of 336 reps, in support of Latuda, an atypical antipsychotic for the treatment of schizophrenia. Psychiatrists can also request samples and track delivery online.

Progenics shifts Relistor marketing duties from Pfizer to Salix

Progenics shifts Relistor marketing duties from Pfizer to Salix

By

Progenics announced that it will hand over commercial duties on Relistor, a subcutaneous injection for opioid-induced constipation, to Salix Pharmaceuticals, beginning in April. Financial terms include a $60 million upfront payment to Progenics, and another potential $290 million in development and sales-based milestone payments.

iRep lets docs sign an iPad for samples

iRep lets docs sign an iPad for samples

By

Sales reps armed with an iPad can collect digital signatures for samples thanks to iRep, a physician detailing application set to launch in mid-February.

Merck, GSK expand sales forces in China

Merck, GSK expand sales forces in China

By

Merck and GSK are both increasing the number of sales reps operating in China, according to separate presentations given by the two companies. In both cases, added reps in emerging markets are helping to offset significant reductions in US sales forces, company executives said.

Email Newsletters